Your shopping cart is currently empty

ALX-5407 ((R)-NFPS) is a selective and orally active GlyT1 inhibitor with an IC50 of 3 nM. It is utilized in research focused on the function of N-methyl-D-aspartate receptors and its relation to schizophrenia.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | ALX-5407 ((R)-NFPS) is a selective and orally active GlyT1 inhibitor with an IC50 of 3 nM. It is utilized in research focused on the function of N-methyl-D-aspartate receptors and its relation to schizophrenia. |
| In vitro | ALX-5407 (0-1 mM) inhibits glycine transport in a GlyT1 or GlyT2-dependent manner, blocking the uptake of [3 H] glycine in rat brains and QT6-1C cells, with an IC50 of 3 nM. At a concentration of 50 nM, ALX-5407 demonstrates slow dissociation kinetics in QT6-1C cells. |
| In vivo | Oral administration of ALX-5407 (1 and 10 mg/kg) increases glycine levels in the prefrontal cortex of rats. |
| Synonyms | (R)-NFPS |
| Molecular Weight | 393.46 |
| Formula | C24H24FNO3 |
| Cas No. | 571147-18-7 |
| Smiles | [C@@H](OC1=CC=C(C=C1)C2=CC=CC=C2)(CCN(CC(O)=O)C)C3=CC=C(F)C=C3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.